Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.19 USD | -0.12% | -1.21% | +3.93% |
Evolution of the average Target Price on Outlook Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Outlook Therapeutics, Inc.
BTIG | |
Chardan Research | |
Guggenheim | |
Brookline Capital Markets | |
Capital One Securities | |
HC Wainwright | |
Cantor Fitzgerald | |
Ascendiant Capital |
EPS Revisions
- Stock Market
- Equities
- OTLK Stock
- Consensus Outlook Therapeutics, Inc.